Abstract:Background: Tumor-associated macrophages (TAMs) constitute a plastic and heterogeneous cell population of the tumor microenvironment (TME) that can regulate tumor proliferation and support resistance to therapy, constituting promising targets for the development of novel anticancer agents. Our previous results suggest that SHP2 plays a crucial role in reprogramming the phenotype of TAMs. Thus, we hypothesized that SHP2+ TAM may predict the treatment efficacy of non-small cell lung cancer NSCLC patients as a biomarker. Methods: We analyzed cancer tissue samples from 79 NSCLC patients using multiplex fluorescence (mIF) staining to visualize various SHP-2+ TAM subpopulations (CD68+SHP2+, CD68+CD86+, CD68 + 206+, CD68+ CD86+SHP2+, CD68+ CD206+SHP2+) and T cells (CD8+ Granzyme B +) of immune cells. The immune cells proportions were quantified in the tumor regions (Tumor) and stromal regions (Stroma), as well as in the overall tumor microenvironment (Tumor and Stroma, TME). The analysis endpoint was overall survival (OS), correlating them with levels of cell infiltration or effective density. Cox regression was used to evaluate the associations between immune cell subsets infiltration and OS. Correlations between different immune cell subsets were examined by Spearman's tests. Results: In NSCLC, the distribution of different macrophage subsets within the TME, tumor regions, and stroma regions exhibited inconsistency. The proportions of CD68+ SHP2+ TAMs (P < 0.05) were higher in tumor than in stroma. And the high infiltration of CD68+SHP2+ TAMs in tumor areas correlated with poor OS (P < 0.05). We found that the expression level of SHP2 was higher in M2-like macrophages than in M1-like macrophages. The CD68+SHP2+ subset proportion was positively correlated with the CD68+CD206+ subset within TME (P < 0.0001), tumor (P < 0.0001) and stroma (P < 0.0001). Conclusions: The high infiltration of CD68+SHP2+ TAMs predict poor OS in NSCLC. Targeting SHP2 is a potentially effective strategy to inhibit M2-phenotype polarization. And it provides a new thought for SHP2 targeted cancer immunotherapy.

Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma

Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer

The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas

Prognostic Value Of Tumor-Associated Macrophages In Clear Cell Renal Cell Carcinoma: A Systematic Review And Meta-Analysis

Prognostic Significance Of Tumor-Associated Macrophages In Breast Cancer: A Meta-Analysis Of The Literature

Prognostic Significance of Tumor-Associated Macrophages in Chondroblastoma and Their Association with Response to Adjuvant Radiotherapy

Spatial interaction and functional status of CD68+SHP2+ macrophages in tumor microenvironment correlate with overall survival of NSCLC

Prognostic Value of Diametrically Polarized Tumor-Associated Macrophages in Renal Cell Carcinoma

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry

Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis.

Tumor-Associated Macrophages in Meningiomas: An Independent Prognostic Factor for Poor Survival Outperforming the Benefits of T cells

Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype

Exosomal Micrornas Induce Tumor-Associated Macrophages Via PPARγ During Tumor Progression in SHH Medulloblastoma.

Infiltration of Diametrically Polarized Macrophages Predicts Overall Survival of Patients with Gastric Cancer after Surgical Resection

Tumor-associated Macrophages Correlate with Phenomenon of Epithelial-Mesenchymal Transition and Contribute to Poor Prognosis in Triple-Negative Breast Cancer Patients.

Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC

The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets

The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment

Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma.